Methotrexate sodium (CAS 15475-56-6) — formula C20H20N8Na2O5, molecular weight 498.4; category inorganic chemicals.
Methotrexate sodium (CAS 15475-56-6) is a chemical raw material in the inorganic chemicals category. Its molecular formula C20H20N8Na2O5 comprises 20 C, 20 H, 8 N, 2 Na, 5 O atoms. Its molecular weight is about 498.4. As a sourcing and distribution partner we help locate and compare this item across domestic and cross-border channels, arranging samples and batch orders with full COA and compliance files.
| CAS Number | 15475-56-6 |
|---|---|
| Molecular Formula | C20H20N8Na2O5 |
| Molecular Weight | 498.4 |
| Applications | Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. In acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. Methotrexate is also indicated in the treatment of meningeal leukemia. Methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous T cell lymphoma), and lung cancer |
| Category | Inorganic Chemicals |
Documented applications: Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. In acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. Methotrexate is also indicated in the treatment of meningeal leukemia. Methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous T cell lymphoma), and lung cancer.
Methotrexate sodium is an inorganic compound with CAS registry number 15475-56-6 and molecular formula C20H20N8Na2O5 (molecular weight 498.4), belonging to the inorganic chemicals segment of chemical raw materials.
CAS number: 15475-56-6
Its molecular formula C20H20N8Na2O5 comprises 20 C, 20 H, 8 N, 2 Na, 5 O atoms.
Also known as: Methotrexate sodium · 甲氨蝶呤钠
Category: inorganic chemicals
The CAS registry number of Methotrexate sodium is 15475-56-6.
Molecular formula C20H20N8Na2O5, molecular weight 498.4.
It is also registered under: Methotrexate sodium, 甲氨蝶呤钠.
Recorded applications: Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. In acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. Methotrexate is also indicated in the treatment of meningeal leukemia. Methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous T cell lymphoma), and lung cancer.
Category: Inorganic Chemicals.
Packaging is agreed per order, from lab-scale packs to bulk, and confirmed with each order rather than fixed on the page. A Certificate of Analysis (COA) ships with every batch and MSDS is available; where the end use carries a regulatory limit (food contact, pharmaceutical or cosmetic), state the standard at enquiry and the grade is set against it.
Independent reference data for Methotrexate sodium (CAS 15475-56-6), compiled from public chemistry databases.
| CAS Registry Number | 15475-56-6 |
|---|---|
| PubChem CID | 11329481 |
| Molecular formula | C20H20N8Na2O5 |
| IUPAC name | disodium;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioate |
| UNII (FDA) | 3IG1E710ZN |
| Molecular Weight | 498.4 |
|---|---|
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 7 |
| Exact Mass | 498.13520433 |
| Monoisotopic Mass | 498.13520433 |
| Topological Polar Surface Area | 216 |
| Heavy Atom Count | 35 |
Methotrexate disodium salt; 7413-34-5; METHOTREXATE SODIUM; Sodium methotrexate; Disodium methotrexate; Abitrexate; Trexall; Methotrexate Lpf; Folex Pfs; Mexate-Aq Preserved; Mexate-Aq; Methotrexate sodium salt; Methotrexate, Sodium Salt; Methotrexate (as disodium); ADX-2191 SODIUM; Methotrexate Preservative Free
| Reported hazard statements | H301 (100%), H311 (98.1%), H315 (100%), H319 (100%), H331 (98.1%), H335 (98.1%), H340 (98.1%), H360 (100%) |
|---|
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
H311 (98.1%): Toxic in contact with skin [Danger Acute toxicity, dermal]
Methotrexate sodium · CAS 15475-56-6 · C20H20N8Na2O5. UNII 3IG1E710ZN.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 甲氨蝶呤钠